<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[generic and ivax corp. Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/generic+and+ivax+corp..html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to generic and ivax corp.]]></description>
	<s:counts start="0" returned="3" found="3" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Teva is The Clear Market Leader Since Its 2006 Purchase of IVAX States New Report Opportunities and Challenges for Generic Drugs In The UK 2007.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200707/ai_n19769415]]></link>
		<description><![CDATA[M2 PRESSWIRE-2 July 2007-Research and Markets: Teva is The Clear  Market Leader Since Its 2006 Purchase of IVAX States New Report  Opportunities and Challenges for Generic Drugs In The UK  2007C1994-2007 M2 COMMUNICATIONS LTD    RDATE:04072007    Dublin - Research and Markets ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 02 Jul 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/clear.html"><![CDATA[Clear]]></category>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[generic]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/leader.html"><![CDATA[leader]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/prescription.html"><![CDATA[prescription]]></category>
		<category domain="http://resources.bnet.com/topic/teva.html"><![CDATA[Teva]]></category>
		<category domain="http://resources.bnet.com/topic/u.k..html"><![CDATA[U.K.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[Bush's Move to Lower Drug Prices Hailed, Attacked.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200210/ai_n21693606]]></link>
		<description><![CDATA[By John Dorschner, The Miami Herald Knight Ridder/Tribune Business  News    Oct. 22--With soaring healthcare costs worrying many voters,  President  Bush's preelection bid to lower drug prices was cheered  Monday by generic drug  manufacturers but was met with suspicion by some  consumer...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 22 Oct 2002 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bush.html"><![CDATA[Bush]]></category>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[generic]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/president.html"><![CDATA[president]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+senate.html"><![CDATA[U.S. Senate]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[Ivax Gets Drug OK]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_199703/ai_n13234104]]></link>
		<description><![CDATA[IVAX CORPORATION, Miami, Fla., has been granted final marketing  approval for etodolac and acyclovir by US Food & Drug  Administration.     Ivax says it has already begun offering 400 mg tablets of etodolac,  the generic equivalent of ...  IVAX CORPORATION, Miami, Fla., has...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 10 Mar 1997 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[generic]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/tablet.html"><![CDATA[tablet]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
</channel>
</rss>
